Vaxart, Inc. OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax
Vaxart, Inc. (VXRT) reported OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax of -$4.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax · last filed 2026-08-06
- Vaxart, Inc. oci, debt securities, available-for-sale, gain (loss), after adjustment and tax for the quarter ending 2026-06-30 was -$4.00K.
- Vaxart, Inc. oci, debt securities, available-for-sale, gain (loss), after adjustment and tax for the quarter ending 2026-03-31 was -$4.00K.
- Vaxart, Inc. oci, debt securities, available-for-sale, gain (loss), after adjustment and tax for the quarter ending 2025-12-31 was -$1.00K.
- Vaxart, Inc. oci, debt securities, available-for-sale, gain (loss), after adjustment and tax for the quarter ending 2025-09-30 was $5.00K, a 88.37% decline year-over-year.
- Vaxart, Inc. oci, debt securities, available-for-sale, gain (loss), after adjustment and tax for fiscal 2023 was $298.00K.
- Vaxart, Inc. oci, debt securities, available-for-sale, gain (loss), after adjustment and tax for fiscal 2022 was -$225.00K.
- Vaxart, Inc. oci, debt securities, available-for-sale, gain (loss), after adjustment and tax for fiscal 2021 was -$74.00K.
| Period end | OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax 3 month | OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax 6 month | OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax 9 month | OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$4.00K 10-Q · filed 2026-08-06 | -$8.00K 10-Q · filed 2026-08-06 | -$9.00K derived: sum of 3 quarters · filed 2026-08-06 | -$4.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | -$4.00K S-1 · filed 2026-05-08 | -$5.00K derived: sum of 2 quarters · filed 2026-05-08 | $0.00 derived: sum of 3 quarters · filed 2026-05-08 | $0.00 derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | -$1.00K derived: S-1 12 month − 10-Q 9 month · filed 2026-05-08 | $4.00K derived: sum of 2 quarters · filed 2026-05-08 | $4.00K derived: sum of 3 quarters · filed 2026-08-06 | -$7.00K S-1 · filed 2026-05-08 |
| 2025-09-30 | $5.00K 10-Q · filed 2025-11-13 | $5.00K derived: sum of 2 quarters · filed 2026-08-06 | -$6.00K 10-Q · filed 2025-11-13 | -$29.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − S-1 3 month · filed 2026-08-06 | -$11.00K 10-Q · filed 2026-08-06 | -$34.00K derived: sum of 3 quarters · filed 2026-08-06 | $9.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | -$11.00K S-1 · filed 2026-05-08 | -$34.00K derived: sum of 2 quarters · filed 2026-05-08 | $9.00K derived: sum of 3 quarters · filed 2026-05-08 | $3.00K derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | -$23.00K derived: S-1 12 month − 10-Q 9 month · filed 2026-05-08 | $20.00K derived: sum of 2 quarters · filed 2026-05-08 | $14.00K derived: sum of 3 quarters · filed 2026-05-08 | $5.00K S-1 · filed 2026-05-08 |
| 2024-09-30 | $43.00K 10-Q · filed 2025-11-13 | $37.00K derived: sum of 2 quarters · filed 2025-11-13 | $28.00K 10-Q · filed 2025-11-13 | $38.00K derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | -$6.00K 10-Q · filed 2025-08-13 | -$15.00K 10-Q · filed 2025-08-13 | -$5.00K derived: sum of 3 quarters · filed 2025-08-13 | $8.00K derived: sum of 4 quarters · filed 2025-08-13 |
| 2024-03-31 | -$9.00K 10-Q · filed 2025-05-13 | $1.00K derived: sum of 2 quarters · filed 2025-05-13 | $14.00K derived: sum of 3 quarters · filed 2025-05-13 | $60.00K derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | $10.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | $23.00K derived: sum of 2 quarters · filed 2025-03-20 | $69.00K derived: sum of 3 quarters · filed 2025-03-20 | $298.00K 10-K · filed 2025-03-20 |
| 2023-09-30 | $13.00K 10-Q · filed 2024-11-13 | $59.00K derived: sum of 2 quarters · filed 2024-11-13 | $288.00K 10-Q · filed 2024-11-13 | $507.00K derived: sum of 4 quarters · filed 2024-11-13 |
| 2023-06-30 | $46.00K 10-Q · filed 2024-08-08 | $275.00K 10-Q · filed 2024-08-08 | $494.00K derived: sum of 3 quarters · filed 2024-08-08 | $385.00K derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $229.00K 10-Q · filed 2024-05-13 | $448.00K derived: sum of 2 quarters · filed 2024-05-13 | $339.00K derived: sum of 3 quarters · filed 2024-05-13 | $239.00K derived: sum of 4 quarters · filed 2024-05-13 |
| 2022-12-31 | $219.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14 | $110.00K derived: sum of 2 quarters · filed 2024-03-14 | $10.00K derived: sum of 3 quarters · filed 2024-03-14 | -$225.00K 10-K · filed 2024-03-14 |
| 2022-09-30 | -$109.00K 10-Q · filed 2023-11-02 | -$209.00K derived: sum of 2 quarters · filed 2023-11-02 | -$444.00K 10-Q · filed 2023-11-02 | -$515.00K derived: sum of 4 quarters · filed 2023-11-02 |
| 2022-06-30 | -$100.00K 10-Q · filed 2023-08-03 | -$335.00K 10-Q · filed 2023-08-03 | -$406.00K derived: sum of 3 quarters · filed 2023-08-03 | -$400.00K derived: sum of 4 quarters · filed 2023-08-03 |
| 2022-03-31 | -$235.00K 10-Q · filed 2023-05-04 | -$306.00K derived: sum of 2 quarters · filed 2023-05-04 | -$300.00K derived: sum of 3 quarters · filed 2023-05-04 | -$304.00K derived: sum of 4 quarters · filed 2023-05-04 |
| 2021-12-31 | -$71.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-15 | -$65.00K derived: sum of 2 quarters · filed 2023-03-15 | -$69.00K derived: sum of 3 quarters · filed 2023-03-15 | -$74.00K 10-K · filed 2023-03-15 |
| 2021-09-30 | $6.00K 10-Q · filed 2022-11-09 | $2.00K derived: sum of 2 quarters · filed 2022-11-09 | -$3.00K 10-Q · filed 2022-11-09 | |
| 2021-06-30 | -$4.00K 10-Q · filed 2022-08-08 | -$9.00K 10-Q · filed 2022-08-08 | ||
| 2021-03-31 | -$5.00K 10-Q · filed 2022-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B |